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It is considered that selection pressure exerted by the host immune response during early HCV infection might influence the outcome of that
infection particularly as it relates to persistence or clearance of the agent. However, it is unclear whether positive selection pressure plays a role in
determining the severity of hepatitis C during the course of persistent HCV infection. To address the evolutionary mechanism by which HCV
escapes from the host immune response and to assess the relationship between viral evolution and hepatic inflammation, we determined 57
sequences (3–5 serial samples per patient) from 5 individuals with persistent HCV infection of genotype 1a who were under long-term follow-up
ranging from 15.6 to 21.6 years. We applied a novel method to estimate serial alternations of selective pressure against the HCVenveloped region
and compared this to fluctuation in transaminase level over time. Positive selection pressure was reduced over time postinfection, as evidenced by
a reduction in nonsynonymous substitutions in the later phase of infection. Furthermore, serum transaminase, as a measure of inflammatory
necrosis of hepatocytes, was reduced in parallel with decreased positive selection pressure. These results suggest that during persistent HCV
infection, the virus faces diminished immune pressure over time, either from mutation to an immune resistant sequence or from immunologic
exhaustion, and that this diminished immune attack is reflected in diminished inflammatory activity. This observation may be applicable to other
viruses characterized by a slow rate of disease progression.
© 2006 Elsevier Inc. All rights reserved.Keywords: HCV; RNA virus; Evolution; Positive selection; Immune response; Selective pressure; Persistent infection; E2; Alanine aminotransferase (ALT)Introduction
Hepatitis C virus (HCV) was identified in 1989 as the major
etiologic agent of non-A and non-B hepatitis (Choo et al.,
1989). As many as 170 million people worldwide are infected
with HCV and it is the world's leading cause of chronic liver
disease (WHO, 1997). Once HCV infects a human, some
patients are able to spontaneously clear the infection, but the
vast majority develops persistent infection. It is postulated that
persistent infection is predicted, at least in part, by an impaired⁎ Corresponding author. Fax: +81 52 842 0021.
E-mail address: ytanaka@med.nagoya-cu.ac.jp (Y. Tanaka).
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doi:10.1016/j.virol.2006.10.041HCV-specific immune response that can be measured directly
by studies of T-cell immunity (Chang et al., 1997), and
indirectly by the degree of immune pressure exerted against
viral envelope proteins (Franco et al., 1995). In contrast, a
strong immune response and high level of immune pressure
early in HCV infection can result in viral clearance and a self-
limited infection (Klenerman et al., 2000; Missale et al., 2004).
Thus, the vigor of positive selection pressure mediated through
the early HCV-specific immune response is thought to be a
determining factor. However, the vigor of positive selection
pressure has been unclear in persistent HCV infection.
Persistent HCV infection is usually clinically mild, but 20%
of patients progress to severe chronic hepatitis and cirrhosis,
occasionally culminating in hepatocellular carcinoma (HCC)
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The precise reasons for this very slow rate of disease progression
in chronic hepatitis C remain an enigma, but since liver damage
is thought to be immune-mediated the implication is that an
impaired HCV-specific immune response simultaneously allows
for viral persistence and insidious liver damage (Ehl et al., 1998).
Although the immune response is impaired, it generates
sufficient immune pressure to generate nonsynonymous viral
escape mutations in acute infection (Farci et al., 2000). Thus a
delicate balance seems to be achieved wherein viral variants
survive the immune response while maintaining essential
replicative functions and liver damage is minimized by an
impaired immune attack. The present study addresses how HCV
escapes the host immune response and how this might translate
to persistent, but low-level liver damage and an insidious course
that is measured in decades rather than years.
A commonway ofmeasuring selective pressure is determining
the ratio of the number of synonymous substitutions per
synonymous site (Ds) to the number of nonsynonymous
substitutions per nonsynonymous site (Dn). Generally, this ratio
has been studied in the E2 envelope protein region of the HCV
genome (Farci et al., 1994; Sheridan et al., 2004; Shimizu et al.,
1994). Much evidence supports that this region is the primary
positively selected region in which Dn is larger than Ds. To
estimate the serial alternation of selective pressure of E2 overFig. 1. Phylogenetic tree assuming the molecular clock. A phylogenetic tree represen
sequence represents the year at which the sequence was isolated. In the isolated years
of most recent common ancestor (MRCA) in each patient.time, we applied a variation of previous methods (Chen and
Wang, 2005; Christie et al., 1999; Manzin et al., 2000). We first
demonstrated the evolutionary relationship among time points by
the phylogenetic tree, and then estimated the selective pressure by
theDn/Ds ratio over the time from the initial infection. In addition,
the alanine aminotransferase (ALT) level was employed as an
indirect serial measure of hepatocyte injury as previously reported
(Matsuoka et al., 1994; Pradat et al., 2002).
Using these combined methods, we succeeded in determin-
ing the serial alternation of both selective pressure and damage
to hepatocytes throughout the long course of chronic HCV
infection.
Results
Comparison of selective pressure among 5 patients
Taking account of the difference in years of isolation for each
clone, we constructed the phylogenetic trees in five patients
(Fig. 1). To know the variation of the selection pressure among
the five patients, the mean Dn/Ds ratio was determined in each
patient. There was a four-fold variation of Dn/Ds ratio among
patients (Fig. 2). Moreover, Dn/Ds ratio was positively
correlated (r=0.76) with the mean ALT values (29–73 time
points), though the association was not significant because ofts the viral evolutionary process occurring in an infected patient. The postfix of a
, 1900 was subtracted from the dominical year. Solid circle indicates the location
Fig. 2. The relationship between Dn/Ds ratio and ALT value among 5 patients.
Each dot indicates a single patient. X-axis is the mean of ALT values over
15 years postinfection. Y-axis is the mean Dn/Ds ratio representing the selective
pressure. Standard deviation of Dn/Ds ratio in each patient is estimated by the
bootstrap method.
Fig. 3. The relationship between Dn/Ds ratio and years postinfection. Each dot
indicates a branch in the phylogenetic tree. X-axis is the mean of the two past
yeas in each branch. Y-axis is Dn/Ds ratio. Standard deviation of Dn/Ds ratio is
shown in each branch. The regression line shows the relationship between Dn/
Ds ratio and years postinfection.
29K. Hanada et al. / Virology 361 (2007) 27–33the small number of patients (Fig. 2). Of note, histological data
also indicated that patients with a high Dn/Ds ratio tended to
have higher HAI inflammatory grades at the latest points
available (NIH1:1993, NIH2:1999, NIH3:1999, NIH4:1995
and NIH5:1995), except for the one patient who had bridging
fibrosis (Table 1 and Fig. 2).
Serial changes in selective pressure over the duration of infection
The overall association between Dn/Ds ratio and the duration
of infection was examined in the five patients (Fig. 3). The
association was negatively correlated (r=−0.44, P<0.01).
Although it is usually considered that nonsynonymous
substitutions are continuous in order to maintain escape from
immune pressure, our results showed that HCV kept reducing
nonsynonymous substitutions over time in comparison with
synonymous substitutions. This apparent decrease in selection
pressure paralleled a decrease in hepatocellular injury as
reflected in declining ALT levels (Fig. 4). Thus, there was a
concomitant decline in Dn/Ds ratio and ALT with increasing
time after initial infection.
Adaptations in genomic regions during persistent infection
The regions affected by positive selection pressure were
identified by the comparison between the number of synon-Table 1
Clinical data of 5 study subjects with chronic hepatitis C virus
Patients Sample
interval (year)
Sample
numbers
Age Gender
1 15.6 14 71 M
2 20.6 7 55 M
3 21.6 17 52 F
4 17.7 5 84 M
5 19 14 76 M
a B: Black African American, W: White Caucasian.
b s.e.: standard error.
c The scores for grading/staging were based on HAI and Knodell fibrosis score (Kymous and nonsynonymous substitutions within the hyper-
variable region of the HCV envelope. Two regions showed
higher Dn/Ds ratios in persistently infected patients (Fig. 5). The
first epitope is in the hyper-variable region and has been reported
to be a B-cell epitope (Weiner et al., 1992). The second epitope
corresponds to amino acid residues 457–462, a region whose
function has not been defined. These two regions appear to have
been positively selected in response to immune pressure but they
are not thought to be functionally constrained regions because
the Dn/Ds ratio of the two regions is much higher than 1.
Two previous papers found positively selected regions in
HCV by the comparison between the rate of synonymous
substitution and the rate of nonsynonymous substitutions
(Suzuki and Gojobori, 2001; Sheridan et al., 2004). However
vaccine design using only synonymous and nonsynonymous
substitutions leads a dilemma that HCV could escape from the
vaccine-induced immune system by nonsynonymous substitu-
tions leading to escape mutants even if the vaccine were
constructed against these critical epitopes. Therefore, we
examined chemically constrained codon regions in the two
regions (Fig. 6). When the proportion of chemically radical
changes in a window (4 codon sites) is smaller than the other
windows, the window is considered to be a more chemically
constrained region. Such constrained regions could be the
targets because the potential amino acid replacements are
limited in their ability to undergo chemical change. ThreeRace a ALT values mean±s.e. b
(Numbers of sample collection)
Degree of
chronic hepatitis c
B 100.3±23.5 (71) 10/3
W 81.1±10.1 (66) 5/1
B 57.2±12.4 (29) 4/1
W 113.9±38.0 (74) 10/1
W 64.2±8.4 (41) 5/1
nodell et al., 1981).
Fig. 4. The relationship between ALT level and years postinfection. Small solid
circles indicate the means of ALT values during the years postinfection for each
patient (0–5, 5–10, >10). Large open circles indicate the mean ALT for each
time period.
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identified in which radical changes were significantly less than
the changes observed in all other windows (P<0.05).
Discussion
Our analyses found a positive correlation between immune
selection pressure and hepatocyte damage over the duration of
HCV infection. Hence the vigor of the immune response may
drive both the extent of ALT elevations and the degree of viral
complexity and diversity. In this study, we used serum ALT
levels to reflect sequential changes in liver cell injury since serial
liver biopsies could not be justified. While this is an indirect
measure of inflammation-associated injury, there was good
correlation between mean ALT level and the Knodell HAI score
in the single liver biopsy obtained for each patient. It has been
previously established that high ALT levels correlate with more
severe outcomes in HCV infection and that persistently normal
or low-level ALT elevations are generally associated with mild
histologic findings. However, severe histologic lesions areFig. 5. Dn/Ds ratio by the window analysis (window size=4 codon sites). X-axis is
window.sometimes observed even in the face of normal serum ALT.
(Matsuoka et al., 1994; Pradat et al., 2002). From these
observations, we believe that the overall disturbance of
hepatocytes can be estimated by mean ALT values during
follow-up and that correlations between positive selection
pressure and liver injury can be validly estimated by serial
measurement of serum ALT levels.
The main finding of the present study is that both the extent
of positive selection pressure and the degree of liver injury were
reduced sequentially during the long course of chronic HCV
infection. We believe these findings to be interrelated since the
vigor of the immune response drives both liver injury and viral
escape. In this regard, several studies have reported that the
immune response against HCV weakens in the later phases of
infection (Takaki et al., 2000; Wang et al., 2002; Wedemeyer
et al., 2002). These results suggest that during persistent HCV
infection, the virus faces diminished immune pressure over
time, either from mutation to an immune resistant sequence or
from immunologic exhaustion, and that this diminished
immune attack is reflected in diminished inflammatory activity.
This would in part explain the indolent course of chronic HCV
infection and the absence of spontaneous resolution once
chronicity is established.
Although anti-viral therapy has become increasingly effec-
tive, the prime goal for the control of global HCV infection is
the development of a prophylactic vaccine and a secondary goal
would be development of a therapeutic vaccine that could
enhance response to antiviral therapy by boosting the immune
system. To examine the potentially immunogenic target, we
utilized a modification of the method of Suzuki and Gojobori
(Suzuki and Gojobori, 1999) in which a phylogenetic tree was
constructed for each patient and the number of synonymous and
nonsynonymous substitutions estimated throughout the phylo-
genetic tree. Using this method, a B-cell epitope within the
hyper-variable region of the HCV envelope was identified as
being under immune pressure and hence this region might serve
as an important immunogen for vaccine development Thethe starting codon site for the window analysis. Y-axis is Dn/Ds ratio for each
Fig. 6. Proportion of chemically radical replacements in two immune related epitopes. X-axis is the starting and ending codon site for the window analysis. Y-axis is the
ratio of chemically radical to conservative replacements for each window. Significant codon sites were indicated as the asterisk [chemically radical changes are smaller
than conservative changes (P<0.05)].
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region of the HCV genome. Similar approaches could be
applied to the entire HCV genome to potentially define other
critical epitopes.
Although this study demonstrated that both positive selec-
tion pressure and liver damage were reduced over the time in
those with persistent infection and mild chronic hepatitis, a
much larger population with diverse hepatitis outcomes would
need to be studied by phylogenetic analysis to ascertain if the
viral evolutionary process, as a reflection of host immune
response, truly dictates the outcome of chronic liver disease in
persistent HCV infection.
Materials and methods
Long-term serial samples
We determined fifty-seven sequences (varying from 3 to 5
serial samples in each patient) from 5 patients with HCV
genotype 1a. All samples were obtained from patients enrolled
in prospective studies of transfusion-associated hepatitis
conducted at National Institutes of Health since 1972 (Alter
et al., 1989). The interval between the first and last sample in the
5 patients for whom serial samples were available ranged from
15.6 to 21.6 years. The clinical data for each patient are shown
in Table 1. ALT values shown in Table 1 are the mean of ALT
values obtained over the duration of follow-up, ranging up to
15 years. All patients had chronic hepatitis without cirrhosis,
and 3 of 5 patients had only mild inflammation. Available
histological results in the five patients were indicated by the
histological activity index (HAI), also known as the Knodell
score (Knodell et al., 1981).
RNA extraction, PCR, and sequencing
To extract total RNA from human sera, a RNA isolator
(Genosys, The Woodlands, TX) was used, with slight
modification from the manufacturer's instructions; Superscript
II RNase H− reverse transcriptase (GIBCO/BRL) was used forreverse transcription. To reduce the number of artifactual
substitutions occurring during PCR, Platinum Pfx DNA
Polymerase (GIBCO/BRL) with very high fidelity was used.
For the PCR in the E2 region, long PCR fragments (core to NS2
regions) were amplified by HCV1- and 2-core-s1 (346–373):
GCACGAATCCTAAACCTCAAAGAAAAAC and HCV1ab-
ns2-as (2540–2565): CTATCAGCAGCATCATCCACAAG-
CAG. The first products were nested by using the following
primers: 45AT-s1 (1290–1310): CGCATGGCNTGGGAYAT-
GATG [n=any, Y=C or T] and HCVE2-as2 (1848–1868):
GAAGCAATAYACYGGRCCACA. The PCR products of a
single target molecule were directly sequenced. If mixed
sequences were detected by direct sequencing, the HCV
amplified products were ligated into pCR-Blunt II-TOPO
Vector and used to transform DH5α high-efficiency competent
cells according to the manufacturer's protocol (Invitrogen
Corp.). The plasmid DNAwas purified using the QIAprep Spin
Miniprep kit (Qiagen Inc, Hilden, Germany) and the presence of
the inserts confirmed by digestion with EcoR1. Sequencing was
performed on more than 5 clones per each point. All clones
were sequenced with Prism Big Dye (Applied Biosystems,
Foster City, California, USA) in an ABI 3100 DNA automated
sequencer. The determined sequences have accession numbers
(AB272166–AB272225).
Estimation of selective pressure in phylogenetic tree
Multiple alignment in each patient was made to match the
coding regions by the computer program, clustalW (Thompson
et al., 1994). The consensus sequence of all the sequences was
used as an outgroup to locate the position of the root in each
phylogenetic tree. The phylogenetic tree was constructed by the
maximum likelihood method premised on a molecular clock in
Fig. 1 (Rambaut, 2000). Taking into account the difference in
years of isolation among the sequences, we estimated the
divergence time of all nodes in the tree. We then inferred
ancestral nucleotide sequences at all nodes of the phylogenetic
tree by the maximum likelihood method (Yang et al., 1995).
These analyses were conducted by the program called PAML.
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ymous site (Ds and Dn) was independently estimated for all
branches by the modified Nei–Gojobori method (Zhang et al.,
1998).
We estimated two kinds of selective pressures, namely the
selective pressure for each patient and the serial selective
pressure over the years since the onset of infection. To
determine the mean selective pressure for each patient, the
mean Dn/Ds ratio was simply estimated in all the branches for
each patient. To determine the serial selective pressure for the
years since the onset of infection, the infected year for each
patient was estimated as the divergence time of the most recent
common ancestor (MRCA) in all the nodes of the phylogenetic
tree (Fig. 1). The year postinfection of each node was defined as
the divergence time of the node minus the divergence time of
MRCA. The year postinfection of each terminal node was
defined as the isolation time of the terminal branch minus the
divergence time of MRCA. This indicated that 2 years could be
applied in each branch. The mean year of 2 years was used as
the year postinfection in each branch. In order to see the change
of selective pressure during the past year, we examined both Dn/
Ds ratio and the mean time postinfection in each branch. When
synonymous substitutions do not occur in several short
branches, the Dn/Ds ratio cannot be calculated. Therefore, to
equalize the weight for the two kinds of substitution, we used
only the branches that included both synonymous and
nonsynonymous substitutions.
Estimation of positively selected regions
Positively selected pressures of a particular region were
identified by the modified version of Suzuki and Gojobori
method (Suzuki and Gojobori, 1999). In this method, a
phylogenetic tree was reconstructed for each patient by the
maximum likelihood method. The ancestral sequence was
inferred at every node in the phylogenetic tree using the
maximum likelihood method. Then, the numbers of synon-
ymous and nonsynonymous substitutions throughout the
phylogenetic tree were estimated in each branch for each
codon site. We independently summed up the total numbers of
synonymous (Ns) and nonsynonymous (Nn) substitutions
occurring in 5 patients for each codon site. The mean numbers
of synonymous (Cs) and nonsynonymous (Cn) sites were
calculated for each codon site by the modified Nei–Gojobori
method. Ds and Dn was calculated as Ns/Cs and Nn/Cn as p-
distance, respectively. To see positively selected pressures, Dn/
Ds was calculated by the window analysis. The window size
used was 4 codon sites.
Moreover, we examined the degree of chemical bias in E2
region. All amino acids were classified into 6 groups by
Zhang's classification, which took account of polarity and
volume (Zhang, 2000). When an amino acid replacement
occurred between the groups, the amino acid replacement was
defined as the chemically radical change. Analogously, when an
amino acid replacement occurred within the single group, the
amino acid replacement was defined as the chemically
conservative change. The number of chemically radical andconservative replacements was counted throughout the phylo-
genetic tree in each codon site. The total numbers of radical
changes and conservative changes were calculated in each
window (the window size=4 codon sites). The ratio of radical
to conservative changes was estimated in each window. Z-value
of each ratio was estimated from the average and standard
deviation in all the windows. P-value was calculated from Z-
value based on the assumption that the distribution of ratios is
the normal distribution.
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